Welcome to the course

“Economic Evaluation of Health Care

Programmes”

Korinna Karampampa, Emelie Heintz & Niklas Zethraeus

Course Objectives

 To give an understanding of theoretical, methodological and

practical issues related to the economic evaluation of health
care programmes
 How economic evaluation can be applied to the health care
sector to inform decisions.
What are your expectations of this course?

 Talk to your colleague: 5 min

 Share with us
Learning outcomes

 Knowledge and understanding

 to describe the theory, principles and methods of economic
evaluation
 to describe and compare basic cost concepts and methods for
analysing uncertainty
 to describe collection of data for economic evaluations and an
introduction to modelling in economic evaluations
 to describe and compare methods for monetary valuations of
health improvements
 Skills and abilities
 to perform a basic economic evaluation
 to select medical interventions according to the decision
rules of cost-effectiveness analysis
 to calculate costs and health outcomes of different medical
interventions
 Judgement and approach
 to critically assess health economic evaluations identified in
databases
 to reflect on the choice of methods for economic evaluation
of health care programmes
 to reflect on the role of health economic evaluation for
different actors in society
Topics – what the course covers

 Cost-effectiveness analysis  Critical assessment of economic

 Cost-utility analysis evaluations
 Cost-benefit analysis  Economic evaluation based on
 Costs clinical trials
 Decision rules  Modelling (introduction; giving a
basic idea)
 Willingness to pay
 Identifying economic
evaluation evidence
 Practical applications
Teaching methods

 Lectures
 Seminars
 Group assignments
- group work exercises
- group work for a specific case (Psoriasis assignment)
- write a report, presentation and opposition
 Individual assignment
Course overview

 A topic is presented and discussed in the morning

 See reading list for preparation

 Working on group work exercises in the afternoon

 Group size of about 4
 Some of the group assignments are compulsory (individual
submission)
- The decision rules of cost-effectiveness analysis (March 22)
- Critical assessment of an economic evaluation (March 26)
Schedule

Microsoft Word
Document
Psoriasis assignment - A reimbursement dossier
Tiger Pharma AB reimbursement case

The
Tiger Pharma
TLV Reimbursement
AB
Board

Application Assessment Decision

1. Your role as Market Access Director at Tiger Pharma AB

 To prepare a reimbursement dossier for your company’s product
Psotop® & a PPT-presentation
 To present the company’s case in a meeting with TLV

TLV=> The Dental and Pharmaceuticals Benefits Agency

The Reimbursement Board (Beslutandenämnden)
Psoriasis assignment - A reimbursement dossier

The
Tiger Pharma
TLV Reimbursement
AB
Board

Application Assessment Decision

2. Your role as TLV staff member (Kansliet, the secretariat)

 Read the reimbursement dossier of your opposition group
 Write a reimbursement recommendation and feedback for the
application to the Reimbursement board
Examination

 Individual active contribution in written report and oral presentation

of group work

 Psoriasis assignment*
Reimbursement dossier & PPT presentation
 Psoriasis assignment *
Recommendation/feedback to the decision board
 Psoriasis assignment presentations*:
Seminar (April 16, 2019)
Examination-cont.

 Individual contribution and active participation during

compulsory group assignments
 The decision rules of cost-effectiveness analysis*
 A critical assessment of an economic evaluation*

 Individual written assignment

Submitted in Ping-Pong April 18 at 08.00
Examination-cont.

 Requirements for the grade pass with distinction (VG), are VG

on the individual written assignment, and pass (G) on remaining
assignments.
Reading material

 Michael F. Drummond, Mark J. Sculpher, Karl Claxton, Greg L.

Stoddart, and George W. Torrance. Methods for the Economic
Evaluation of Health Care Programmes. Oxford: Oxford University
Press, 2015.
 Morris S, Devlin N, and Parkin D. Economic Analysis in health
care. John Wiley & Sons, John Wiley & Sons, 2012.
 Scientific articles and reports will be added during the course (see
the reading list).
 Faculty
 Niklas Zethraeus (NZ) – KI – COURSE DIRECTOR
 Korinna Karampampa (KK) – KI
 Emelie Heintz (EH) – Swedish Agency for Health Technology
Assessment and Assessment of Social Services SBU, KI & Stockholm
County Council (SLL)
 Peter Lindgren (PL) – KI & The Swedish institute for Health Economics
(IHE)
 Freddie Henriksson (FH) - Sanofi
 Ulrika Schüldt Håård (UH) - KI
 Nathalie Eckard (NE) - The Dental and Pharmaceutical Benefits Agency
(TLV)
 Sofie Gustafsson (SG) - The Dental and Pharmaceutical Benefits
Agency (TLV)
 Patrik Hidefjäll (PH) - The National Board of Health and Welfare
(Socialstyrelsen)
 Lotta Mathiesen (LM) – Karolinska Institutet University Library (KIB)
 Kristina Burström (KB) - KI
Groups for Psoriasis assignment
& afternoon assignments
Group 1: Alagic Zlatan, Besong Eta Oben Calvin
Boerkoel Aletta, El Halabi Soha

Group 2: Hu Jiahao, Johansson Malin, Jónsson Egill,

Cristea Anathea Cora

Group 3: Kanjilimadom Rahul, Kim Sunhee, Kirubi

Beatrice Wangari, Low Eunice Syn Yii

Group 4: Madsen Mona, Magnusdottir Karoline,

Mahmudah Noor Afif, Persson Mathias

Group 5: Shotton Lydia, Sparreman Ensjö Joel,

Subban Inola Simone, Süli Orsolya Réka

Group 6: Sæthre Silje, Wu Yan, Yang Xi, Zhang Jing